BONT-A Specific Neutra™ Antibody (V3S-0324-FY24), Human IgG1 lambda (CAT#: V3S-0324-FY24)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is a human IgG1, λ monoclonal antibody designed to target BoNT/A. It is suitable for use in ELISA, Neut, WB, and Inhib assay. The antibody exhibited a 92% inhibition of the cleavage induced by BoNT/A. Through ELISA, it was observed that the antibody specifically binds to the BoNT/A LC, and not to the BoNT/A heavy chain. Furthermore, when administered alone, the antibody demonstrated potent in vivo neutralization, and in collaboration with an antibody specific for the HC.
Clonality Monoclonal
Host Species Human
Target Species C. botulinum
Neutralization Potency An equimolar mix of 6A and 4LCA antibodies neutralized BoNT/A with a potency of 10,000 LD50/mg antibody.
Affinity KD = 31 pM
Isotype Human IgG1, lambda

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; Neut; WB; Inhib

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target BONT-A
Alternative Name Botulinum Toxin Type A; BONT-A
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry